Higher percentages of cells expressing HLA-DR, CD69, CD38, and CD71 were detected in tumors than in NT lung and blood from healthy donors and NSCLC patients (Figure 2A, upper panel). This evidence concerns the gene CD69 and non-small cell lung carcinoma.